Moxifloxacin, a New Antibiotic Designed to Treat Community-Acquired Respiratory Tract Infections: A Review of Microbiologic and Pharmacokinetic-Pharmacodynamic Characteristics
Pharmacotherapy - United States
doi 10.1592/phco.20.4.245.34880
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 1, 2000
Authors
Publisher
Wiley